Chevy Chase Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $196M | Sell |
|
|||||
2025
Q1 | $215M | Sell |
|
|||||
2024
Q4 | $179M | Sell |
|
|||||
2024
Q3 | $208M | Sell |
|
|||||
2024
Q2 | $213M | Buy |
|
|||||
2024
Q1 | $186M | Sell |
|
|||||
2023
Q4 | $181M | Buy |
|
|||||
2023
Q3 | $150M | Buy |
|
|||||
2023
Q2 | $146M | Buy |
|
|||||
2023
Q1 | $107M | Buy |
|
|||||
2022
Q4 | $62.4M | Buy |
|
|||||
2022
Q3 | $45.4M | Buy |
|
|||||
2022
Q2 | $43.5M | Buy |
|
|||||
2022
Q1 | $40M | Buy |
|
|||||
2021
Q4 | $33.5M | Sell |
|
|||||
2021
Q3 | $28.9M | Sell |
|
|||||
2021
Q2 | $33.3M | Sell |
|
|||||
2021
Q1 | $37.5M | Sell |
|
|||||
2020
Q4 | $44.6M | Sell |
|
|||||
2020
Q3 | $56.1M | Sell |
|
|||||
2020
Q2 | $64.2M | Sell |
|
|||||
2020
Q1 | $54.4M | Buy |
|
|||||
2019
Q4 | $49.5M | Sell |
|
|||||
2019
Q3 | $38.6M | Sell |
|
|||||
2019
Q2 | $41.8M | Sell |
|
|||||
2019
Q1 | $39.1M | Buy |
|
|||||
2018
Q4 | $37.6M | Sell |
|
|||||
2018
Q3 | $47M | Sell |
|
|||||
2018
Q2 | $42.2M | Buy |
|
|||||
2018
Q1 | $40.5M | Sell |
|
|||||
2017
Q4 | $37.9M | Sell |
|
|||||
2017
Q3 | $38.6M | Buy |
|
|||||
2017
Q2 | $32M | Buy |
|
|||||
2017
Q1 | $26.6M | Buy |
|
|||||
2016
Q4 | $17.3M | Buy |
|
|||||
2016
Q3 | $20.5M | Sell |
|
|||||
2016
Q2 | $20.6M | Buy |
|
|||||
2016
Q1 | $18.7M | Buy |
|
|||||
2015
Q4 | $25.5M | Buy |
|
|||||
2015
Q3 | $20.9M | Buy |
|
|||||
2015
Q2 | $23.8M | Buy |
|
|||||
2015
Q1 | $22.3M | Buy |
|
|||||
2014
Q4 | $21.5M | Buy |
|
|||||
2014
Q3 | $20.3M | Buy |
|
|||||
2014
Q2 | $16M | Sell |
|
|||||
2014
Q1 | $12.2M | Buy |
|
|||||
2013
Q4 | $12.7M | Buy |
|
|||||
2013
Q3 | $12.7M | Buy |
|